Prostate Cancer - Results from #26060

Split-course, high-dose palliative pelvic radiotherapy for locally progressive hormone-refractory prostate cancer - Abstract April 6, 2012

A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer - Abstract April 6, 2012

Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer - Abstract April 6, 2012

Bother problems in prostate cancer patients after curative treatment - Abstract April 6, 2012

Salvage High energy focalized ultrasound (HIFU) in prostate cancer after radiotherapy - Abstract April 6, 2012

Pharmaco-economic aspects of Sipuleucel-T - Abstract April 6, 2012

Prognostic value of Her-2/neu and clinicopathologic factors for evaluating progression and disease-specific death in Chinese men with prostate cancer - Abstract April 6, 2012

Recovery of urinary function after radical prostatectomy: Identification of trajectory cluster groups - Abstract April 6, 2012

Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from Radiation Therapy Oncology Group protocol 94-06 - Abstract April 6, 2012

Posterior urethral complications of the treatment of prostate cancer - Abstract April 5, 2012

Significant addition to treatment options for bone metastasis in prostate cancer - Abstract April 5, 2012

Rescue cryotherapy for prostate cancer after radiotherapy - Abstract April 5, 2012

Prostate Specific Antigen (PSA), yet how much damage? - Abstract April 5, 2012

Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? - Abstract April 5, 2012

Sipuleucel-T for the treatment of metastatic prostate cancer: Promise and challenges - Abstract April 5, 2012

Antigen specific T-cell responses against tumor antigens are controlled by regulatory T cells in patients with prostate cancer - Abstract April 5, 2012

Association of rash with outcomes in a randomized phase II trial evaluating cetuximab in combination with mitoxantrone plus prednisone after docetaxel for metastatic castration-resistant prostate cancer - Abstract April 5, 2012

Single-port laparoscopic radical prostatectomy: Initial experience and technical points to reduce its difficulties April 5, 2012

Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer - Abstract April 4, 2012

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group - Abstract April 4, 2012

Page 1304 of 1436